These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel mechanism of non-feminizing estrogens in neuroprotection. Engler-Chiurazzi EB; Covey DF; Simpkins JW Exp Gerontol; 2017 Aug; 94():99-102. PubMed ID: 27818250 [TBL] [Abstract][Full Text] [Related]
4. Estrogen-like compounds for ischemic neuroprotection. Simpkins JW; Yang SH; Liu R; Perez E; Cai ZY; Covey DF; Green PS Stroke; 2004 Nov; 35(11 Suppl 1):2648-51. PubMed ID: 15472107 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Zhao L; Wu TW; Brinton RD Brain Res; 2004 Jun; 1010(1-2):22-34. PubMed ID: 15126114 [TBL] [Abstract][Full Text] [Related]
6. The assessment of non-feminizing estrogens for use in neuroprotection. Yi KD; Perez E; Yang S; Liu R; Covey DF; Simpkins JW Brain Res; 2011 Mar; 1379():61-70. PubMed ID: 21111714 [TBL] [Abstract][Full Text] [Related]
7. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097 [TBL] [Abstract][Full Text] [Related]
8. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Marin R; Guerra B; Alonso R; Ramírez CM; Díaz M Curr Neurovasc Res; 2005 Oct; 2(4):287-301. PubMed ID: 16181121 [TBL] [Abstract][Full Text] [Related]
9. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. Zhao L; Brinton RD BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications. Etgen AM; Jover-Mengual T; Zukin RS Front Neuroendocrinol; 2011 Aug; 32(3):336-52. PubMed ID: 21163293 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Liu R; Yang SH; Perez E; Yi KD; Wu SS; Eberst K; Prokai L; Prokai-Tatrai K; Cai ZY; Covey DF; Day AL; Simpkins JW Stroke; 2002 Oct; 33(10):2485-91. PubMed ID: 12364742 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotection and estrogen receptors. Simpkins JW; Singh M; Brock C; Etgen AM Neuroendocrinology; 2012; 96(2):119-30. PubMed ID: 22538356 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons. Nixon E; Simpkins JW Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4739-47. PubMed ID: 22700711 [TBL] [Abstract][Full Text] [Related]
15. [Synthetic estrogens: some new pharmacological actions and mechanisms]. Kosano H Nihon Rinsho; 2008 Jan; 66(1):104-10. PubMed ID: 18186255 [TBL] [Abstract][Full Text] [Related]